IntrinsicIntrinsic
← Scroll for more →

Financial Statements — SYRA

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Cash & Equivalents2.382.122.921.611.982.312.492.402.701.593.243.280.02
Accounts Receivable1.521.470.870.920.930.89--0.68--------1.05
Total Current Assets4.163.753.932.743.213.433.653.354.062.834.454.781.24
Property, Plant & Equipment0.000.010.010.010.010.010.020.030.030.060.070.080.09
Total Non-current Assets*0.060.080.020.030.050.040.080.330.360.410.100.141.37
Total Assets4.233.833.942.773.263.473.723.684.433.244.554.922.61
Accounts Payable----------0.560.330.100.210.500.65----
Total Current Liabilities1.201.201.580.671.051.061.270.610.880.901.100.912.38
Total Non-current Liabilities*0.000.000.000.000.000.000.000.190.220.240.000.001.46
Total Liabilities1.201.201.580.671.051.061.270.801.091.151.100.913.84
Retained Earnings(8.88)(9.23)(9.48)(9.72)(9.59)(9.36)(9.30)(8.82)(8.32)(7.90)(6.51)(5.06)(4.07)
Total Stockholder Equity3.022.632.362.102.212.412.462.883.332.093.454.01(1.23)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total Revenue2.562.392.271.731.691.951.862.012.251.971.751.771.58
Cost of Revenue1.371.331.301.141.131.191.271.551.591.621.571.181.03
Gross Profit1.191.070.970.590.550.750.590.460.670.350.180.580.55
Research & Development0.050.050.010.000.000.030.04(0.01)0.030.280.28----
Selling, General & Admin0.220.240.210.240.250.290.290.300.290.460.400.470.23
Total Operating Expenses0.890.810.780.730.790.821.060.961.101.741.621.570.90
Operating Income0.300.250.19(0.14)(0.23)(0.06)(0.47)(0.50)(0.43)(1.39)(1.44)(0.99)(0.34)
Interest Expense------------0.00------0.000.010.01
Pretax Income0.30------------------------
Tax Provision(0.04)----------------------0.00
Net Income0.340.250.24(0.13)(0.23)(0.06)(0.47)(0.50)(0.42)(1.39)(1.45)(1.00)(0.35)
Basic EPS0.020.020.02(0.01)(0.02)(0.01)(0.04)(0.01)(0.06)(0.21)(0.22)(0.16)(0.08)
Diluted EPS0.020.020.02(0.01)(0.02)(0.01)(0.04)(0.01)(0.06)(0.21)(0.22)(0.16)(0.08)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Operating Cash Flow0.33(0.72)1.36(0.29)(0.24)(0.07)0.16(0.21)(0.41)(1.50)(0.80)(1.76)(1.00)
Capital Expenditures--------------0.000.000.010.010.000.02
Free Cash Flow*--------------(0.21)(0.41)(1.51)(0.81)(1.76)(1.02)
Investing Cash Flow--------------0.000.00(0.01)(0.01)0.00(0.02)
Financing Cash Flow(0.07)(0.08)(0.05)(0.07)(0.09)(0.11)(0.06)(0.09)1.52(0.13)0.765.021.03
← Scroll for more columns →

* Derived from reported values